Empagliflozin 25 MG trials for Heart failure

All Empagliflozin 25 MG trials · All Heart failure trials

Phase breakdown

Recruiting trials studying Empagliflozin 25 MG for Heart failure

• EMPAgliflozin in Heart Failure With PReserved Ejection Fraction and End Stage Renal Disease
  NCT06249945 · Phase: Phase 4 · Ages: 20 Years and older · Sex: All (male and female) · 2 locations
• Empagliflozin in Heart Failure with Reduced Ejection Fraction and End Stage Renal Disease
  NCT06249932 · Phase: Phase 4 · Ages: 20 Years and older · Sex: All (male and female) · 4 locations
• SGLT2 Inhibitors, Ketones, and Cardiovascular Benefit Research Plan
  NCT05057806 · Phase: Early Phase 1 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location

Common questions

How many trials study Empagliflozin 25 MG for Heart failure?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.